Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedAdded a MedlinePlus Genetics topic covering Multiple myeloma, expanding core content and proper noun coverage.SummaryDifference0.1%
- Check10 days agoChange DetectedUpdates include a government-funding notice and a new v3.2.0 revision, with removal of a MedlinePlus Genetics topic (Multiple myeloma) and the old v3.1.0 tag.SummaryDifference1%
- Check17 days agoChange DetectedCore terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' with a version bump to v3.1.0.SummaryDifference0.1%
- Check25 days agoChange DetectedAdded new MedlinePlus Genetics topic: Multiple myeloma. This expands core content by introducing information about a specific disease.SummaryDifference0.1%
- Check32 days agoChange DetectedUpdated to Revision v3.0.2; removed the MedlinePlus Genetics topic (Multiple myeloma), the v3.0.1 note, and the Back to Top link.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.